文献速递产科

改变妊娠期糖尿病诊断标准的影响(CDC4G):一项医疗成本分析及阶梯楔形整群随机试验

Implications of Changing the Diagnostic Criteria for Gestational Diabetes Mellitus (CDC4G): A Healthcare Cost Analysis Alongside a Stepped Wedge Cluster Randomised Trial.
PubMed 文献 · BJOG · 2025-09-10

瑞典基于登记的成本分析嵌套于CDC4G阶梯楔形整群随机试验,比较2018年从SWE-GDM标准切换至WHO-2013标准对医疗资源使用的影响。人群水平上,WHO-2013标准与产科监测成本增加€94.0(自助法CI 24.5-169.1)、分娩护理成本增加€20.4(-33.5至75.4)、新生儿护理成本增加€331.0(75.1-589.0)相关;受影响亚组中上述成本分别增加€606.9、€348.5和€129.3。作者认为瑞典实施WHO-2013标准与产科监测和分娩成本增加相关,新生儿护理成本增加存在较大不确定性。

要点

  • 人群水平上WHO-2013标准与产科监测成本增加€94.0(自助法CI 24.5-169.1)相关。
  • 受影响亚组产科监测成本增加€606.9(377.7-872.4),为人群水平增加的主要驱动。
  • 新生儿护理成本增加€331.0(75.1-589.0),但不确定性较大。

核心结论

  • 在瑞典实施WHO-2013妊娠期糖尿病诊断标准与人群水平产科监测和分娩成本增加相关,主要由受影响亚组驱动。
  • 新生儿护理成本增加与较大不确定性相关。
  • 对资源使用变化的详细理解可指导决策以减轻成本增加。

研究设计与样本

  • 基于登记的成本分析,嵌套于CDC4G阶梯楔形整群随机试验,从医疗保健视角进行。
  • 研究人群为47 080名孕妇及其婴儿,瑞典采用基于危险因素的妊娠期糖尿病筛查。
  • 2018年从SWE-GDM标准切换至WHO-2013标准,分析在人群水平和受干预影响的亚组(即血浆葡萄糖值介于SWE-GDM与WHO-2013标准之间者)中重复进行,并采用自助法进行敏感性分析。

主要发现

  • 人群水平上,WHO-2013标准与产科监测成本增加€94.0(自助法CI 24.5-169.1)相关。
  • 人群水平上,WHO-2013标准与分娩护理成本增加€20.4(自助法CI -33.5至75.4)相关。
  • 人群水平上,WHO-2013标准与新生儿护理成本增加€331.0(自助法CI 75.1-589.0)相关。
  • 受影响亚组中,产科监测成本增加€606.9(自助法CI 377.7-872.4),分娩护理成本增加€348.5(自助法CI 126.0-542.0),新生儿护理成本增加€129.3(自助法CI -559.0至980.9)。

临床怎么用

  • 原文结论指出,对资源使用变化的详细理解可指导决策以减轻成本增加。

局限性

  • 原文结论指出新生儿护理成本的增加与较大不确定性相关。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To estimate the effect on healthcare resource use after introducing the World Health Organization diagnostic criteria (WHO-2013) for gestational diabetes mellitus (GDM) compared to former criteria in Sweden (SWE-GDM). DESIGN: A cost-analysis alongside the Changing Diagnostic Criteria for Gestational Diabetes (CDC4G) randomised controlled trial. SETTING: Sweden, with risk-factor based screening for GDM. POPULATION: 47 080 pregnant women and their infants. METHODS: A register-based cost-analysis from a healthcare perspective alongside a stepped-wedge cluster RCT of switching from SWE-GDM to WHO-2013 criteria in 2018. Analyses were made on the population level and repeated in the subgroup affected by the intervention, that is, those with plasma glucose values between SWE-GDM and WHO-2013 criteria. Sensitivity analysis by bootstrapping was performed. MAIN OUTCOME MEASURES: Estimated costs for obstetric surveillance (including GDM-management), delivery and neonatal healthcare until 28 days postpartum. RESULTS: On a population level, the WHO-2013 criteria were associated with increased costs of obstetric surveillance (adjusted mean [bootstrap confidence interval]) €94.0 [24.5-169.1], delivery care €20.4 [-33.5 to 75.4] and neonatal care €331.0 [75.1-589.0] per pregnancy, and in the affected subgroup €606.9 [377.7-872.4], €348.5 [126.0-542.0] and €129.3 [-559.0 to 980.9] respectively. CONCLUSIONS: Implementation of the WHO-2013 criteria in Sweden was associated with increased costs for obstetric surveillance and delivery on a population level, driven by the affected subgroup. The increased costs for neonatal care were associated with large uncertainty. A detailed understanding of the changes in resource use can guide decisions to mitigate cost increases.

来源:BJOG,查看原文。版权归原作者所有。

引用

  1. de Brun M, Johansson N, Simmons D, et al. Implications of Changing the Diagnostic Criteria for Gestational Diabetes Mellitus (CDC4G): A Healthcare Cost Analysis Alongside a Stepped Wedge Cluster Randomised Trial. BJOG. 2025. PMID: 40931348. doi:10.1111/1471-0528.18364

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。